Osteal Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $15.6M

  • Investors
  • 9

Osteal Therapeutics General Information

Description

Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. The company's therapeutics offers a drug and device combination product to treat orthopedic infections, infected joint prosthesis, and their consequences, and provide a fast and reliable treatment option, enabling orthopedic surgeons to offer an effective treatment for musculoskeletal diseases.

Contact Information

Formerly Known As
JPS, Joint Purification Systems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4835 Lyndon B. Johnson Freeway
  • Suite 635
  • Dallas, TX 75244
  • United States
+1 (469)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4835 Lyndon B. Johnson Freeway
  • Suite 635
  • Dallas, TX 75244
  • United States
+1 (469)

Osteal Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Osteal Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 05-Nov-2025 $15.6M Completed Clinical Trials - Phase 2
5. Later Stage VC (Series D) 22-May-2024 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 11-Sep-2023 Completed Clinical Trials - Phase 2
3. Debt - General 28-Jun-2022 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series B) 17-Dec-2021 $30.2M $37.7M Completed Clinical Trials - Phase 2
1. Later Stage VC (Series A) 18-Apr-2018 $7.41M $7.41M Completed Clinical Trials - General
To view Osteal Therapeutics’s complete valuation and funding history, request access »

Osteal Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 11,250,481 $0.000100 $2.9 $2.9 1x $2.9 27.83%
Series A 4,335,995 $0.000100 $1.79 $1.79 1x $1.79 10.72%
To view Osteal Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Osteal Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with muscul
Drug Discovery
Dallas, TX
49 As of 2025

Glasgow, United Kingdom
 

New Haven, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Osteal Therapeutics Competitors (3)

One of Osteal Therapeutics’s 3 competitors is Causeway Therapeutics, a Venture Capital-Backed company based in Glasgow, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Causeway Therapeutics Venture Capital-Backed Glasgow, United Kingdom
Cybrexa Therapeutics Venture Capital-Backed New Haven, CT
Vir Biotechnology Formerly VC-backed San Francisco, CA
You’re viewing 3 of 3 competitors. Get the full list »

Osteal Therapeutics Patents

Osteal Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026044016-A1 Irrigation system and methods of use Pending 21-Aug-2024
WO-2026039544-A1 Methods of treating a localized infection with locally administered antibiotics Pending 14-Aug-2024
AU-2024225462-A1 Irrigation system and methods of use Pending 21-Feb-2023
EP-4669386-A1 Irrigation system and methods of use Pending 21-Feb-2023
US-12521484-B2 Irrigation system and methods of use Active 21-Feb-2023 A61M5/16809
To view Osteal Therapeutics’s complete patent history, request access »

Osteal Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Osteal Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
HM Venture Partners Venture Capital Minority
Zimmer Biomet Holdings Corporation Minority
Asteroid Partners Venture Capital Minority
Gideon Strategic Partners Limited Partner Minority
GOS Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Osteal Therapeutics FAQs

  • When was Osteal Therapeutics founded?

    Osteal Therapeutics was founded in 2013.

  • Where is Osteal Therapeutics headquartered?

    Osteal Therapeutics is headquartered in Dallas, TX.

  • What is the size of Osteal Therapeutics?

    Osteal Therapeutics has 49 total employees.

  • What industry is Osteal Therapeutics in?

    Osteal Therapeutics’s primary industry is Drug Discovery.

  • Is Osteal Therapeutics a private or public company?

    Osteal Therapeutics is a Private company.

  • What is the current valuation of Osteal Therapeutics?

    The current valuation of Osteal Therapeutics is .

  • What is Osteal Therapeutics’s current revenue?

    The current revenue for Osteal Therapeutics is .

  • How much funding has Osteal Therapeutics raised over time?

    Osteal Therapeutics has raised $133M.

  • Who are Osteal Therapeutics’s investors?

    HM Venture Partners, Zimmer Biomet Holdings, Asteroid Partners, Gideon Strategic Partners, and GOS Capital are 5 of 9 investors who have invested in Osteal Therapeutics.

  • Who are Osteal Therapeutics’s competitors?

    Causeway Therapeutics, Cybrexa Therapeutics, and Vir Biotechnology are competitors of Osteal Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process